Differences in Postprandial Glucose Changes
An Intervention Comparing Changes in the Plasma Glucose Profile Over a Three-hour Timespan in Persons With T2DM Following Caribbean Shake vs Glucerna Intake: A Double Blinded, Cross-over Design
1 other identifier
interventional
25
0 countries
N/A
Brief Summary
Following a meal, in nondiabetic individuals, blood glucose rises to peak at 1hr and returns to baseline in 2 - 3 hours. In T2DM, this peak is higher and prolonged. Meal plans for persons with T2DM should comprise evenly spaced, complex carbohydrate portions in order to avoid post-prandial glucose spikes. Researchers have developed an expanded line of Caribbean-flavoured, low-calorie meal-replacement shakes which have been formulated to match the macronutrient and caloric content of a commercially available brand. In this trial investigators aim to (1) examine the change in glucose levels post intake of Caribbean vs the commercially available brand and (2) to conduct a comparative sensory analysis of the two shakes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2023
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 5, 2023
CompletedFirst Posted
Study publicly available on registry
July 24, 2023
CompletedStudy Start
First participant enrolled
November 15, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 15, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
November 15, 2024
CompletedJuly 24, 2023
July 1, 2023
6 months
July 5, 2023
July 13, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Change in plasma glucose concentration post oral intake of shake
30 minutes, 60 minutes and 120 minutes post oral intake of shake
Secondary Outcomes (1)
Sensory analysis of taste, texture, smell and appearance of shakes
within 1hour post oral intake of shake
Study Arms (2)
Shake 1 then Shake 2
EXPERIMENTALParticipants will consume 1 bottle of shake 1 and take their normal morning medications. After this 3ml blood samples will be taken via the cannula at 30mins, 60mins and 120 mins post meal. During the waiting period between phlebotomy, a sensory analysis questionnaire which asks participants to rate the taste, appearance, texture and smell of the product. After a 1-week washout period, the entire protocol will be repeated using Shake 2.
Shake 2 then Shake 1
EXPERIMENTALParticipants will consume 1 bottle of Shake 2 and take their normal morning medications. After this 3ml blood samples will be taken via the cannula at 30mins, 60mins and 120 mins post meal. During the waiting period between phlebotomy, a sensory analysis questionnaire which asks participants to rate the taste, appearance, texture and smell of the product. After a 1-week washout period, the entire protocol will be repeated using Shake 1.
Interventions
Oral administration of Caribbean low-calorie meal-replacement shake then commercial low-calorie meal-replacement shake
Oral administration of commercial low-calorie meal-replacement shake then Caribbean low-calorie meal-replacement shake
Eligibility Criteria
You may qualify if:
- A diagnosis of T2DM for any length of time,
- last HbA1C (within the last 6 months) of \< / = 8%
You may not qualify if:
- \. On insulin for any length of time
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- The participants will be blinded to the intervention as the shakes will be given in unmarked containers - however as the flavours are very different it is likely that participants will be able to tell them apart. Data analysts will be blinded.
- Purpose
- OTHER
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 5, 2023
First Posted
July 24, 2023
Study Start
November 15, 2023
Primary Completion
May 15, 2024
Study Completion
November 15, 2024
Last Updated
July 24, 2023
Record last verified: 2023-07